TrialThe Journal of clinical investigation2015

Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease.

Neil E McCarthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.